Overton Brooks Research Corporation Inc
- Assets
- $122.4k
- Revenue
- $264.3k
- Investments
- $0.0
- Employees
- 6
- Location
- Shreveport, LA
- Founding
- 12/1992
- Data as of
- 09/2023
- EIN
- 72-1196625
Organization Overview
Overton Brooks Research Corporation Inc is located in Shreveport, LA. The organization was established in 1992. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 09/2023, Overton Brooks Research Corporation Inc employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Overton Brooks Research Corporation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, Overton Brooks Research Corporation Inc generated $264.3k in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 50.1% each year . All expenses for the organization totaled $198.0k during the year ending 09/2023. While expenses have increased by 28.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE SOLE PURPOSE OF THE CORPORATION IS TO SUPPORT AND FACILITATE MEDICAL RESEARCH ACTIITIES OF ITS MEMBERS IN CONJUNCTION WITH THE OVERTON BROOKS VETERANS AFFAIR MEDICAL CENTER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
NATIONAL INSTITUTES OF HEALTH (NIH) STUDY 2016-05 ALL OF US WITH DR. PHILIP HADDAD AS PRINCIPAL INVESTIGATOR(1) THE PROGRAM INVITES PEOPLE IN THE USA TO HELP BUILD DIVERSE HEALTH DATABASES. AT THIS VA, THE GOAL IS 40 ENROLLEES MONTHLY. A BLOOD DRAW IS REQUIRED. (2) THE GOAL IS TO ACCELERATE MEDICAL RESEARCH BREAKTHROUGHS BY DELIVERING ONE OF THE LARGEST BIOMEDICAL DATASETS TO RESEARCHERS WITH ONE MILLION OR MORE ENROLLED. (3) IT MAY TAKE YEARS TO UNDERSTAND HOW A VARIABLE IS LINKED TO A DISEASE OR TREATMENT, BUT BY CREATING A DATABASE OF THIS SIZE/SCOPE, NIH HOPES TO SPEED UP THIS PROCESS.
NOVARTIS PHARMACEUTICALS CORPORATION STUDY QI23-001 WITH DR. SANDRA BROWN AS PRINCIPAL INVESTIGATOR. (1) THIS STUDY CONTACTS VETERANS RECEIVING CARE AT OVERTON BROOKS VAMC CONCERNING THEIR CHOLESTEROL LEVELS. THERE ARE OVER 37,000 VETERANS SERVED AT THIS FACILITY. (2) THE LONG TERM GOAL IS TO IMPROVE THE CHOLESTEROL HEALTH THROUGH CONTACT WITH A HEALTH CARE COACH. (3) THIS IS A MULTI-SITE STUDY WITH NO FIXED STATISTICAL GOAL OTHER THAN TO APPLY EXISTING KNOWLEDGE TO DEVELOP INDIVIDUALIZED CARE SOLUTIONS TO LOWER CHOLESTEROL IN THE VETERAN POPULATION. THIS IS NOT RESEARCH REQUIRING INSTITUTIONAL REVIEW BOARD REVIEW.
STUDY 1074: PROMINENT PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES
CSL BEHRING, LLC STUDY 1214 WITH DR. NEERAJ TANDON AS PRINCIPAL INVESTIGATOR(1) THIS PHARMACEUTICAL STUDY IS INVESTIGATING THE EFFICACY AND SAFETY OF A DRUG CALLED CSL 112. (2) GLOBALLY 10,584 PARTICIPANTS HAVE ENROLLED, BUT ONLY ONE FROM THIS VAMC DUE TO THE STRICT INCLUSION/EXCLUSION CRITERIA. THE LONG TERM GOAL IS TO REDUCE FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WHO HAVE HAD A HEART ATTACK. (3) THE ONE VETERAN ENROLLED LOCALLY HAS HAD NO ADVERSE EVENTS AND IS BEING FOLLOWED PER PROTOCOL.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Philip Haddad MD Director | Trustee | 5 | $0 |
Patrick Mcgauly MD Director | Trustee | 5 | $0 |
Karen Johnson PHD Director | Trustee | 5 | $0 |
John T Gleason Lt Col Retired Executive Director | Officer | 5 | $520 |
Richard L Crockett President | Officer | 5 | $0 |
Laura A Huff Treasurer | Officer | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $264,222 |
| Investment income | $36 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $264,258 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $760 |
| Compensation of current officers, directors, key employees. | $760 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $154,413 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $11,394 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $2,756 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $181 |
| Information technology | $528 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,923 |
| All other expenses | $1,251 |
| Total functional expenses | $197,965 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $122,431 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $122,431 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $122,431 |
| Total liabilities and net assets/fund balances | $122,431 |